1. Home
  2. SIBN vs TCPC Comparison

SIBN vs TCPC Comparison

Compare SIBN & TCPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SIBN
  • TCPC
  • Stock Information
  • Founded
  • SIBN 2008
  • TCPC 2006
  • Country
  • SIBN United States
  • TCPC United States
  • Employees
  • SIBN N/A
  • TCPC N/A
  • Industry
  • SIBN Medical/Dental Instruments
  • TCPC Finance/Investors Services
  • Sector
  • SIBN Health Care
  • TCPC Finance
  • Exchange
  • SIBN Nasdaq
  • TCPC Nasdaq
  • Market Cap
  • SIBN 717.0M
  • TCPC 603.8M
  • IPO Year
  • SIBN 2018
  • TCPC 2012
  • Fundamental
  • Price
  • SIBN $16.29
  • TCPC $7.24
  • Analyst Decision
  • SIBN Strong Buy
  • TCPC Sell
  • Analyst Count
  • SIBN 4
  • TCPC 2
  • Target Price
  • SIBN $25.75
  • TCPC $6.75
  • AVG Volume (30 Days)
  • SIBN 338.7K
  • TCPC 452.8K
  • Earning Date
  • SIBN 08-04-2025
  • TCPC 11-05-2025
  • Dividend Yield
  • SIBN N/A
  • TCPC 16.85%
  • EPS Growth
  • SIBN N/A
  • TCPC N/A
  • EPS
  • SIBN N/A
  • TCPC N/A
  • Revenue
  • SIBN $185,262,000.00
  • TCPC $239,535,768.00
  • Revenue This Year
  • SIBN $19.92
  • TCPC N/A
  • Revenue Next Year
  • SIBN $16.28
  • TCPC N/A
  • P/E Ratio
  • SIBN N/A
  • TCPC N/A
  • Revenue Growth
  • SIBN 22.93
  • TCPC 3.11
  • 52 Week Low
  • SIBN $11.70
  • TCPC $6.27
  • 52 Week High
  • SIBN $20.05
  • TCPC $9.72
  • Technical
  • Relative Strength Index (RSI)
  • SIBN 48.65
  • TCPC 52.42
  • Support Level
  • SIBN $15.95
  • TCPC $7.09
  • Resistance Level
  • SIBN $16.88
  • TCPC $7.21
  • Average True Range (ATR)
  • SIBN 0.49
  • TCPC 0.09
  • MACD
  • SIBN 0.10
  • TCPC 0.03
  • Stochastic Oscillator
  • SIBN 60.14
  • TCPC 91.67

About SIBN SI-BONE Inc.

SI-BONE Inc is a medical device company, that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and Internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma.

About TCPC BlackRock TCP Capital Corp.

BlackRock TCP Capital Corp is an externally-managed specialty finance company focused on middle-market lending. Its investment objective is to achieve high total returns through current income and capital appreciation, with an emphasis on principal protection. It seeks to achieve investment objective through investments in debt securities of middle-market companies. The group generates returns through a combination of the receipt of contractual interest payments on debt investments and origination and similar fees, and, to a lesser extent, equity appreciation through options, warrants, conversion rights or direct equity investments.

Share on Social Networks: